Skip to content

Clinical trials

Lymphoproliferative Disorders trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Country / region: Russia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20111
20151
20202
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AO GENERIUM1
Acerta Pharma BV1
Amgen1
Amgen Research (Munich) GmbH1
European Association of Urology Research Foundation1
I.M. Sechenov First Moscow State Medical University1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders7
Lymphatic Diseases3
Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Immune System Diseases2
Immunoproliferative Disorders2
Leukemia2
Anemia1
Anemia, Hemolytic, Autoimmune1
Burkitt Lymphoma1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.